Atlas Trials

Stage IV Nasopharyngeal Carcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Nasopharyngeal Carcinoma

RecordFirmDate
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864)Alain Algazi2020-12-01
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies (NCT03044743)Yang Yang2017-04-07
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer (NCT03049358)Stanford University2016-12-01
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510)University of Washington2015-10-08
GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma (NCT01655628)Sun Yat-sen University2012-07-01
Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma (NCT01616849)Sun Yat-sen University2012-05-01

Track Stage IV Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.